期刊文献+

De—Nol治疗幽门螺杆菌相关性门脉高压性胃病的疗效观察 预览 被引量:4

Observation of the efficacy of De-Nol in Helicobacter pylori associated portal hypertensive gastropathy
在线阅读 免费下载
分享 导出
摘要 41例幽门螺杆菌感染相关性的门脉高压性胃病(PHG)患者,随机分成De-Nol(240mg)组,法莫替丁(20mg)组,De-Nol(240mg)+法莫替丁(20mg)+甲硝唑(0.2g)组,一日2次,疗程为8周。结果证明:De-Nol在促进胃粘膜好转率(64.3%),幽门螺杆菌清除率(78.6%)方面的疗效优于法莫替丁组的(50.1%和7.1%)(P〈0.05)。两者在溃疡愈合率症状缓解率差异无 41 cases of patients with Helicobacter pylori (Hp) associatcd portal hypertensive gastropathy (PHG) were randomly allocated to receive De-Nol tablet 240mg, Famotidine 20 mg and Metronidiazolum 0.2 twice daily for a trial comparing these drug effects of short-term in two month. The results demonstrated that the effects of De-nol is better than that of Famotidine in protective gastric mucosa and Hp clearation (P<0.05). De-Nol as a code drug treated the diseases of acute gastric mucosa of PHG, digestive ulceration and Hp infected gastroenterologic diseases. The triple agents with De-Nol and famotidine and metronidiazolum are introduced. It is obvious that the therapeutic effect of patients with PHG by De-Nol related an role of clearation for Hp.
作者 杨冬华 黄纯织 Yang Dong-hua Huang Chun-chi Fan Zi-rong et alDepartment of Gastroenterology, zhujiang HospitalThe first Military medical university 
出处 《胃肠病学和肝病学杂志》 CAS 1997年第2期 169-171,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 德诺 甲硝唑 门脉高压笥胃病 幽门螺杆菌 胃疾病  De-Nol, Famotidine, metronidiazolum, portal hyertensive gastropathy, helicobacter pylori
  • 相关文献

同被引文献26

引证文献4

二级引证文献38

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈